Published in Infect Immun on December 07, 2009
Mycoplasma genitalium: from Chrysalis to multicolored butterfly. Clin Microbiol Rev (2011) 2.39
Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women. PLoS Pathog (2011) 1.67
Estradiol-Treated Female Mice as Surrogate Hosts for Neisseria gonorrhoeae Genital Tract Infections. Front Microbiol (2011) 1.33
Mycoplasma, Ureaplasma, and adverse pregnancy outcomes: a fresh look. Infect Dis Obstet Gynecol (2010) 1.25
Serine-rich repeat proteins and pili promote Streptococcus agalactiae colonization of the vaginal tract. J Bacteriol (2011) 1.10
Genetic variation in the complete MgPa operon and its repetitive chromosomal elements in clinical strains of Mycoplasma genitalium. PLoS One (2010) 1.03
Persistent Mycoplasma genitalium infection of human endocervical epithelial cells elicits chronic inflammatory cytokine secretion. Infect Immun (2012) 1.02
Mycoplasma genitalium: an emerging cause of pelvic inflammatory disease. Infect Dis Obstet Gynecol (2011) 0.98
Mycoplasma genitalium infection activates cellular host defense and inflammation pathways in a 3-dimensional human endocervical epithelial cell model. J Infect Dis (2013) 0.84
Extensive variation and rapid shift of the MG192 sequence in Mycoplasma genitalium strains from patients with chronic infection. Infect Immun (2014) 0.82
Chlamydial infection increases gonococcal colonization in a novel murine coinfection model. Infect Immun (2011) 0.82
Persistence, immune response, and antigenic variation of Mycoplasma genitalium in an experimentally infected pig-tailed macaque (Macaca nemestrina). Infect Immun (2013) 0.82
Mycoplasma genitalium infection is associated with microscopic signs of cervical inflammation in liquid cytology specimens. J Clin Microbiol (2014) 0.82
Extracellular Proteins of Mycoplasma synoviae. ISRN Vet Sci (2012) 0.80
Variability of trinucleotide tandem repeats in the MgPa operon and its repetitive chromosomal elements in Mycoplasma genitalium. J Med Microbiol (2011) 0.80
Increased Risk of Endometriosis in Patients With Lower Genital Tract Infection: A Nationwide Cohort Study. Medicine (Baltimore) (2016) 0.78
Development and utilization of a custom PCR array workflow: analysis of gene expression in mycoplasma genitalium and guinea pig (Cavia porcellus). Mol Biotechnol (2015) 0.78
Use of a Guinea pig-specific transcriptome array for evaluation of protective immunity against genital chlamydial infection following intranasal vaccination in Guinea pigs. PLoS One (2014) 0.76
Quantitative assessment of Mycoplasma hemadsorption activity by flow cytometry. PLoS One (2014) 0.76
Sexually transmitted diseases and infertility. Am J Obstet Gynecol (2017) 0.75
Mycoplasma genitalium and preterm delivery at an urban community health center. Int J Gynaecol Obstet (2013) 0.75
Experimental infection of pig-tailed macaques (Macaca nemestrina) with Mycoplasma genitalium. Infect Immun (2016) 0.75
A newly discovered mycoplasma in the human urogenital tract. Lancet (1981) 5.45
The complex role of estrogens in inflammation. Endocr Rev (2007) 4.07
Polymerase chain reaction for detection of Mycoplasma genitalium in clinical samples. J Clin Microbiol (1991) 3.76
Mucopurulent cervicitis and Mycoplasma genitalium. J Infect Dis (2003) 2.88
Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases. J Eur Acad Dermatol Venereol (2004) 2.78
Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect Immun (1994) 2.73
Isolation of Mycoplasma genitalium strains from the male urethra. J Clin Microbiol (1996) 2.32
Serological investigation of Mycoplasma genitalium in infertile women. Hum Reprod (2001) 2.24
Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection. Sex Transm Infect (2005) 2.20
Salpingitis in mice induced by human strains of Chlamydia trachomatis. Br J Exp Pathol (1986) 2.03
Chlamydia trachomatis-induced salpingitis in mice. J Infect Dis (1983) 1.99
Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum. Sex Transm Dis (2005) 1.96
Mycoplasma pneumoniae and Mycoplasma genitalium mixture in synovial fluid isolate. J Clin Microbiol (1995) 1.90
Tetracycline treatment does not eradicate Mycoplasma genitalium. Sex Transm Infect (2003) 1.87
Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice. Infect Immun (1999) 1.86
Microbiological and serological study of non-gonococcal urethritis with special reference to Mycoplasma genitalium. Genitourin Med (1985) 1.83
Mycoplasma genitalium in the cervices of Japanese women. Sex Transm Dis (1997) 1.64
Mycoplasma genitalium, Chlamydia trachomatis, and tubal factor infertility--a prospective study. Fertil Steril (2007) 1.59
Mycoplasma genitalium: an organism commonly associated with cervicitis among west African sex workers. Sex Transm Infect (2005) 1.58
Intrastrain heterogeneity of the mgpB gene in Mycoplasma genitalium is extensive in vitro and in vivo and suggests that variation is generated via recombination with repetitive chromosomal sequences. Infect Immun (2006) 1.49
Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial. Sex Transm Infect (2007) 1.42
Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS One (2008) 1.39
Mycoplasma genitalium infection and persistence in a cohort of female sex workers in Nairobi, Kenya. Sex Transm Dis (2007) 1.39
Association of Mycoplasma genitalium and HIV infection: a systematic review and meta-analysis. AIDS (2009) 1.37
Genetic diversity of the biofilm covering Montacuta ferruginosa (Mollusca, bivalvia) as evaluated by denaturing gradient gel electrophoresis analysis and cloning of PCR-amplified gene fragments coding for 16S rRNA. Appl Environ Microbiol (1998) 1.36
mgpB and mgpC sequence diversity in Mycoplasma genitalium is generated by segmental reciprocal recombination with repetitive chromosomal sequences. Mol Microbiol (2007) 1.36
Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease. Curr Opin Infect Dis (2008) 1.36
Animal models of Mycoplasma genitalium urogenital infection. Isr J Med Sci (1987) 1.31
Mycoplasma genitalium: an efficient strategy to generate genetic variation from a minimal genome. Mol Microbiol (2007) 1.30
Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease. Sex Transm Infect (2008) 1.30
Interaction of Mycoplasma genitalium with host cells: evidence for nuclear localization. Microbiology (2008) 1.23
Mycoplasma genitalium-encoded MG309 activates NF-kappaB via Toll-like receptors 2 and 6 to elicit proinflammatory cytokine secretion from human genital epithelial cells. Infect Immun (2008) 1.22
Intracellular Mycoplasma genitalium infection of human vaginal and cervical epithelial cells elicits distinct patterns of inflammatory cytokine secretion and provides a possible survival niche against macrophage-mediated killing. BMC Microbiol (2009) 1.21
Isolation of Mycoplasma genitalium from first-void urine specimens by coculture with Vero cells. J Clin Microbiol (2007) 1.20
Defining the mycoplasma 'cytoskeleton': the protein composition of the Triton X-100 insoluble fraction of the bacterium Mycoplasma pneumoniae determined by 2-D gel electrophoresis and mass spectrometry. Microbiology (2001) 1.19
Mycoplasma genitalium in the joints of two patients with arthritis. Eur J Clin Microbiol Infect Dis (1994) 1.17
Chlamydia trachomatis persistence: an update. Microbiol Res (2005) 1.16
Cervicitis and genitourinary symptoms in women culture positive for Mycoplasma genitalium. Am J Reprod Immunol (2006) 1.14
Non-occurrence of Mycoplasma genitalium in clinical specimens. Eur J Clin Microbiol Infect Dis (1988) 1.10
Single-nucleotide polymorphisms in the rRNA operon and variable numbers of tandem repeats in the lipoprotein gene among Mycoplasma genitalium strains from clinical specimens. J Clin Microbiol (2004) 1.04
Factors influencing the ability of different mycoplasmas to colonize the genital tract of hormone-treated female mice. Int J Exp Pathol (1993) 1.04
Characteristics of murine model of genital infection with Chlamydia trachomatis and effects of therapy with tetracyclines, amoxicillin-clavulanic acid, or azithromycin. Antimicrob Agents Chemother (1994) 1.03
Identification and characterization of immunogenic proteins of mycoplasma genitalium. Clin Vaccine Immunol (2006) 1.03
Neisseria gonorrhoeae colonises the genital tract of oestradiol-treated germ-free female mice. Microb Pathog (1990) 0.89
Distribution of ecto 5'-nucleotidase on Mycoplasma species associated with arthritis. FEMS Microbiol Lett (2000) 0.87
Mycoplasma genitalium urethritis in men. Int J Antimicrob Agents (2004) 0.85
Proliferative changes in the genital tissue of female mice during the oestrous cycle. Cell Tissue Kinet (1990) 0.84
Models of infection due to mycoplasmas, including Mycoplasma fermentans, in the genital tract and other sites in mice. Clin Infect Dis (1993) 0.83
Failure of Mycoplasma pneumoniae infection to confer protection against Mycoplasma genitalium: observations from a mouse model. J Med Microbiol (2001) 0.80
The presence of bacteria in the synovial fluid of the temporomandibular joint and clinical significance: preliminary study. J Oral Maxillofac Surg (2003) 0.78
Generation of HIV latency in humanized BLT mice. J Virol (2011) 2.20
Mutations conferring resistance to SCH6, a novel hepatitis C virus NS3/4A protease inhibitor. Reduced RNA replication fitness and partial rescue by second-site mutations. J Biol Chem (2005) 1.54
Quantification and comparison of toll-like receptor expression and responsiveness in primary and immortalized human female lower genital tract epithelia. Am J Reprod Immunol (2008) 1.49
Screening for hepatitis C virus antiviral activity with a cell-based secreted alkaline phosphatase reporter replicon system. Antiviral Res (2005) 1.45
CD1d degradation in Chlamydia trachomatis-infected epithelial cells is the result of both cellular and chlamydial proteasomal activity. J Biol Chem (2007) 1.30
Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection. J Clin Microbiol (2011) 1.30
Mycoplasma genitalium-encoded MG309 activates NF-kappaB via Toll-like receptors 2 and 6 to elicit proinflammatory cytokine secretion from human genital epithelial cells. Infect Immun (2008) 1.22
Intracellular Mycoplasma genitalium infection of human vaginal and cervical epithelial cells elicits distinct patterns of inflammatory cytokine secretion and provides a possible survival niche against macrophage-mediated killing. BMC Microbiol (2009) 1.21
Impact of immunization with glycoprotein D2/AS04 on herpes simplex virus type 2 shedding into the genital tract in guinea pigs that become infected. J Infect Dis (2005) 1.08
Role of primary human alveolar epithelial cells in host defense against Francisella tularensis infection. Infect Immun (2007) 1.08
Antiviral suppression vs restoration of RIG-I signaling by hepatitis C protease and polymerase inhibitors. Gastroenterology (2008) 1.07
Macrophages sustain HIV replication in vivo independently of T cells. J Clin Invest (2016) 1.04
Quantification of poly(I:C)-mediated protection against genital herpes simplex virus type 2 infection. J Virol (2006) 1.04
Commensal bacteria modulate innate immune responses of vaginal epithelial cell multilayer cultures. PLoS One (2012) 1.01
Innate immune mediator profiles and their regulation in a novel polarized immortalized epithelial cell model derived from human endocervix. J Reprod Immunol (2011) 0.99
A Vaxfectin(®)-adjuvanted HSV-2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes. Vaccine (2012) 0.93
Viral load and acute otitis media development after human metapneumovirus upper respiratory tract infection. Pediatr Infect Dis J (2012) 0.92
Modification of primary and recurrent genital herpes in guinea pigs by passive immunization. J Gen Virol (2002) 0.90
High-throughput multistrain polymerase chain reaction quantification of Chlamydia trachomatis from clinical and preclinical urogenital specimens. Diagn Microbiol Infect Dis (2009) 0.87
FSL-1, a bacterial-derived toll-like receptor 2/6 agonist, enhances resistance to experimental HSV-2 infection. Virol J (2009) 0.86
Global expression of molecular transporters in the human vaginal tract: implications for HIV chemoprophylaxis. PLoS One (2013) 0.85
Immunostimulatory CpG treatment for genital HSV-2 infections. J Antimicrob Chemother (2003) 0.84
Mucosal treatments for herpes simplex virus: insights on targeted immunoprophylaxis and therapy. Future Microbiol (2010) 0.80
Quantification of bacterial uropathogens in preclinical samples using real-time PCR assays. Curr Microbiol (2013) 0.78
Determining Persistence of Bocavirus DNA in the Respiratory Tract of Children by Pyrosequencing. Pediatr Infect Dis J (2016) 0.78
An immunomodulating dipeptide, SCV-07, is a potential therapeutic for recurrent genital herpes simplex virus type 2 (HSV-2). Int J Antimicrob Agents (2008) 0.78
Development and utilization of a custom PCR array workflow: analysis of gene expression in mycoplasma genitalium and guinea pig (Cavia porcellus). Mol Biotechnol (2015) 0.78
Association between body mass index, sexually transmitted infections, and contraceptive compliance. J Womens Health (Larchmt) (2013) 0.77
Immunomodulatory and antibacterial effects of cystatin 9 against Francisella tularensis. Mol Med (2013) 0.76
Correction: Intraluminal Flagellin Differentially Contributes to Gut Dysbiosis and Systemic Inflammation following Burn Injury. PLoS One (2017) 0.75